Key Details
Price
$99.23Last Dividend
$0.81Annual Revenue
$60.12 BAnnual EPS
$0.14Annual ROE
0.87%Beta
0.23Events Calendar
Next earnings date:
Feb 04, 2025Recent quarterly earnings:
Oct 31, 2024Recent annual earnings:
Feb 01, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Dec 16, 2024Next split:
N/ARecent split:
June 03, 2021Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
On Tuesday, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) announced that it has approved a treatment from Merck for a rare lung disease known as pulmonary arterial hypertension.
On the most recent trading day, Merck (MRK) closed at $98.37, which is a decrease of 1.33% compared to its last closing price.
Merck (MRK) finished the last trading day at $99.45, which is an increase of 0.08% compared to the day before.
On Monday, the U.S. Food and Drug Administration's website revealed that Merck will stop producing its medication for a bacterial infection that can cause deadly diarrhea.
Merck is a major global pharmaceutical company that makes various medicines, vaccines, and products for animal health, with a market value of $258 billion. The United States is its biggest market, making up around 47% of its total sales. Since around the fiscal year 2020, Merck has been experiencing steady growth, particularly due to the rapid increase in sales of Keytruda, which is growing at a rate higher than 5% each year.
Be careful, Eli Lilly and Novo Nordisk. Merck (MRK -1.48%) is eagerly aiming to enter the weight-loss drug market.
Merck has shared encouraging results from two phase III trials that tested a single-tablet treatment combining doravirine and islatravir for adults with HIV-1.
Users of Zacks.com have been paying a lot of attention to Merck (MRK) lately. Therefore, it's important to understand the key information that could influence the stock's future.
Merck & Co., Inc. (MRK) shares are not changing much in price on Thursday, but they are still following a downward trend.
We have just put together a list of the 10 Dogs of the Dow Dividend Stocks to consider for investment. In this article, we will examine how Merck & Co., Inc. (NYSE:MRK) compares to other dividend stocks. Investors who focus on dividends usually prefer stocks with high yields, which influences their investment strategies.
FAQ
- What is the primary business of Merck & Co?
- What is the ticker symbol for Merck & Co?
- Does Merck & Co pay dividends?
- What sector is Merck & Co in?
- What industry is Merck & Co in?
- What country is Merck & Co based in?
- When did Merck & Co go public?
- Is Merck & Co in the S&P 500?
- Is Merck & Co in the NASDAQ 100?
- Is Merck & Co in the Dow Jones?
- When was Merck & Co's last earnings report?
- When does Merck & Co report earnings?
- Should I buy Merck & Co stock now?